Sjögren disease (SjD) is an autoimmune disease driven by autoimmune CD4 + T cells that leads to an immune-mediated loss of lacrimal glands (LG). Meibomian glands are lipid-producing glands in the eyelids that help prevent tear evaporation. While the role of T cells in LG-mediated destruction is well established, it is unknown whether pathogenic T cells can cause MG dysfunction (MGD). Herein, we investigated whether autoimmune CD4 + T cells induce MGD and characterized the pathophysiologic mechanisms using an adoptive transfer model. T cells were isolated from CD25KO (KO CD4 ) or wild-type (WT CD4 ) mice and transferred into Rag1 KO mice. In comparison, KO cells were co-adoptively transferred with WT regulatory T cells (KO CD4 + WT Tregs ). Our results demonstrate that CD25KO CD4 + T recipients had MG dropout, CD4 + IFN-γ + infiltration, increased MHC II presentation within the periglandular area, MG fibrosis, decreased lipid production, and upregulation of pathways related to inflammation, including Type II interferon signaling. Rag1 KO, WT CD4 , and KO CD4 + WT Tregs recipients exhibited minimal inflammation in the periglandular MG area. These results indicate that autoimmune CD4 + T cells are sufficient to cause MGD, and healthy young regulatory T cells can prevent T-cell-mediated damage. Our findings provide mechanistic insights into the pathogenesis of autoimmune SjD and could impact how patients are managed in the clinic.
No takes yet. Share an insight, caveat, or question.
Scholand et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: